Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1726347
PUBLISHER: Grand View Research | PRODUCT CODE: 1726347
Cell Reprogramming Market Size, Share & Trends Analysis Report By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Cell Reprogramming Market Growth & Trends:
The global cell reprogramming market size is estimated to reach USD 664.2 million by 2030, registering a CAGR of 8.55% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing adoption of cell reprogramming in cancer research and growing focus on cell reprogramming, are expected to drive market growth. In addition, emphasis on collaborations and partnerships among key players is anticipated to boost market growth. Advancements in the mRNA reprogramming technique allow rapid, safe, and efficient generation of clinical-grade human iPS cells using somatic tissue. In addition, as mRNA is lower in size, the transfection process is simpler than other reprogramming vectors. When utilizing difficult-to-reprogram samples, mRNA reprogramming improves reprogramming efficiency by 1%.
Furthermore, this method can generate high-quality human iPS cells from somatic tissue more rapidly and safely, which increases the demand for mRNA reprogramming technology. Furthermore, there is the capability to reprogram human stem cells back to a naive state, allowing replication of the earliest developmental stages. For instance, in March 2022, researchers at the Babraham Institute identified key factors facilitating this reprogramming process. This new knowledge streamlines and expedites the generation of naive pluripotent stem cells for researchers. Moreover, cell reprogramming is experiencing growth due to significant government and public funding. This backing is a response to various benefits it offers to the healthcare sector, particularly in terms of its potential applications in medicine.
Furthermore, cell reprogramming has recently been repositioned from the lab to clinic by researchers. This shift is prominent in various clinical & academic research initiatives, encompassing regenerative medicine, disease modeling, and studies related to medication toxicity & drug discovery. The clinical utility of cell reprogramming, especially in regenerative medicine, has been significant. Increased strategic initiatives aimed at innovative product development through cell reprogramming is due to a growth in the research and academic institute segment. For instance, the California Institute for Regenerative Medicine funded research groups to advance cellular reprogramming into therapeutic applications with a clinical focus.
Cell Reprogramming Market Report Highlights:
- The mRNA reprogramming technology segment held the largest revenue share of 32.63% in 2024, due to the ease of use, speed, safety, and efficiency while generating high-quality human iPS cells from somatic tissue.
- The research application segment led the market with a share of 67.30% in 2024. One of the main factors driving its growth include ongoing research in the field of cell reprogramming using stem cells.
- The research & academic institute end-use segment held a revenue share of 67.30% in 2024. The growth is due to usage of cell reprogramming in a various clinical & academic research initiatives, including those involving regenerative therapies, disease modeling, and drug toxicity/drug discovery studies.
- North America dominated the global industry in 2024, with a revenue share of 39.69%, owing to the presence of key players in this region.
Product Code: GVR-4-68039-966-2
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Information Analysis
- 1.2.2. Market Platform & Data Visualization
- 1.2.3. Data Validation & Publishing
- 1.3. Research Assumptions
- 1.4. Information Procurement
- 1.4.1. Primary Research
- 1.5. Information or Data Analysis
- 1.6. Market Platform & Validation
- 1.7. Market Model
- 1.8. Global Market: CAGR Calculation
- 1.9. Objectives
- 1.9.1. Objective 1:
- 1.9.2. Objective 2:
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing focus on cell reprogramming
- 3.2.1.2. Increasing adoption of cell reprogramming in cancer research
- 3.2.1.3. Emphasis on collaborations and partnerships among key players
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Challenges associated with iPSCs
- 3.2.2.2. Limited awareness regarding treatment option
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
- 4.1. Technology Segment Dashboard
- 4.2. Cell Reprogramming Market: Technology Movement Analysis
- 4.3. Sendai Virus-based Reprogramming
- 4.3.1. Sendai Virus-based Reprogramming Market, 2018 - 2030 (USD Million)
- 4.4. mRNA Reprogramming
- 4.4.1. mRNA Reprogramming Market, 2018 - 2030 (USD Million)
- 4.5. Episomal Reprogramming
- 4.5.1. Episomal Reprogramming Market, 2018 - 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others Reprogramming Market, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
- 5.1. Application Segment Dashboard
- 5.2. Cell Reprogramming Market: Application Movement Analysis
- 5.3. Research
- 5.3.1. Research Market, 2018 - 2030 (USD Million)
- 5.4. Therapeutics
- 5.4.1. Therapeutics Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Cell Reprogramming Market: End-use Movement Analysis
- 6.3. Research & Academic Institutes
- 6.3.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
- 6.4. Biotechnology & Pharmaceutical Companies
- 6.4.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Regional Dashboard
- 7.2. Cell Reprogramming Market Share by Region, 2018- 2030
- 7.3. North America
- 7.3.1. North America Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. U.S. Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Canada Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Mexico Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Europe Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. UK Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Germany Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. France Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Italy Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Spain Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Denmark Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key Country Dynamics
- 7.4.8.2. Competitive Scenario
- 7.4.8.3. Sweden Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key Country Dynamics
- 7.4.9.2. Competitive Scenario
- 7.4.9.3. Norway Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Japan Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. China Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. India Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Competitive Scenario
- 7.5.5.3. Australia Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Competitive Scenario
- 7.5.6.3. Thailand Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Competitive Scenario
- 7.5.7.3. South Korea Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Brazil Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Argentina Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. MEA Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. South Africa Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Saudi Arabia Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. UAE Cell Reprogramming Market, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Kuwait Cell Reprogramming Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis
- 8.4. Company Profiles/Listing
- 8.4.1. Thermo Fisher Scientific, Inc.
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Allele Biotechnology and Pharmaceuticals Inc.
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. ALSTEM
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. STEMCELL Technologies
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Merck KGaA
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Bio-Techne
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. REPROCELL Inc.
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Lonza
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. FUJIFILM Corporation (Fujifilm Cellular Dynamics)
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Mogrify Limited
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Thermo Fisher Scientific, Inc.
Product Code: GVR-4-68039-966-2
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Global Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 4 Global Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 5 Global Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 6 Global Cell Reprogramming Market, By Region, 2018 - 2030 (USD Million)
- Table 7 North America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
- Table 8 North America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 9 North America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 10 North America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 11 U.S. Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 12 U.S. Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 13 U.S. Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 14 Canada Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 15 Canada Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 16 Canada Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 17 Mexico Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 18 Mexico Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 19 Mexico Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 20 Europe Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
- Table 21 Europe Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 22 Europe Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 23 Europe Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 24 UK Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 25 UK Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 26 UK Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 27 Germany Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 28 Germany Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 29 Germany Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 30 France Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 31 France Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 32 France Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 33 Spain Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 34 Spain Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 35 Spain Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 36 Italy Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 37 Italy Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 38 Italy Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 39 Denmark Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 40 Denmark Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 41 Denmark Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 42 Norway Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 43 Norway Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 44 Norway Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 45 Sweden Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 46 Sweden Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 47 Sweden Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 48 Asia Pacific Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
- Table 49 Asia Pacific Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 50 Asia Pacific Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 51 Asia Pacific Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 52 China Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 53 China Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 54 China Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 55 Japan Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 56 Japan Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 57 Japan Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 58 India Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 59 India Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 60 India Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 61 South Korea Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 62 South Korea Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 63 South Korea Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 64 Australia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 65 Australia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 66 Australia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 67 Thailand Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 68 Thailand Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 69 Thailand Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 70 Latin America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
- Table 71 Latin America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 72 Latin America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 73 Latin America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 74 Brazil Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 75 Brazil Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 76 Brazil Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 77 Argentina Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 78 Argentina Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 79 Argentina Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 80 MEA Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
- Table 81 MEA Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 82 MEA Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 83 MEA Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 84 South Africa Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 85 South Africa Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 86 South Africa Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 87 UAE Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 88 UAE Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 89 UAE Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 90 Saudi Arabia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 91 Saudi Arabia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 92 Saudi Arabia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
- Table 93 Kuwait Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
- Table 94 Kuwait Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
- Table 95 Kuwait Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value chain-based sizing & forecasting
- Fig. 6 Market formulation & validation
- Fig. 7 Cell Reprogramming market segmentation
- Fig. 8 Market snapshot
- Fig. 9 Market trends & outlook
- Fig. 10 Market driver relevance analysis (current & future impact)
- Fig. 11 Market restraint relevance analysis (current & future impact)
- Fig. 12 PESTEL analysis
- Fig. 13 Porter's five forces analysis
- Fig. 14 Global cell reprogramming market: Technology outlook and key takeaways
- Fig. 15 Global cell reprogramming market: Technology movement analysis
- Fig. 16 Global cell reprogramming market, for sendai virus-based reprogramming, 2018 - 2030 (USD Million)
- Fig. 17 Global cell reprogramming market, for mRNA reprogramming, 2018 - 2030 (USD Million)
- Fig. 18 Global cell reprogramming market, for episomal reprogramming, 2018 - 2030 (USD Million)
- Fig. 19 Global cell reprogramming market, for others, 2018 - 2030 (USD Million)
- Fig. 20 Global cell reprogramming market: Application outlook and key takeaways
- Fig. 21 Global cell reprogramming market: Application movement analysis
- Fig. 22 Global cell reprogramming market, for research, 2018 - 2030 (USD Million)
- Fig. 23 Global cell reprogramming market, for therapeutic, 2018 - 2030 (USD Million)
- Fig. 24 Global cell reprogramming market: End-use outlook and key takeaways
- Fig. 25 Global cell reprogramming market: End-use movement analysis
- Fig. 26 Global cell reprogramming market, for research & academic institutes, 2018 - 2030 (USD Million)
- Fig. 27 Global cell reprogramming market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
- Fig. 28 Regional marketplace: Key takeaways
- Fig. 29 Regional outlook, 2022 & 2030
- Fig. 30 North America cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 31 U.S. Key country dynamics
- Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 33 Canada Key country dynamics
- Fig. 34 Canada cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 35 Mexico Key country dynamics
- Fig. 36 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 37 Europe cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 38 Germany Key country dynamics
- Fig. 39 Germany cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 40 UK Key country dynamics
- Fig. 41 UK cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 42 France Key country dynamics
- Fig. 43 France cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 44 Italy Key country dynamics
- Fig. 45 Italy cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 46 Spain Key country dynamics
- Fig. 47 Spain cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 48 Denmark Key country dynamics
- Fig. 49 Denmark cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 50 Sweden Key country dynamics
- Fig. 51 Sweden cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 52 Norway Key country dynamics
- Fig. 53 Norway cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 54 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 55 Japan Key country dynamics
- Fig. 56 Japan cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 57 China Key country dynamics
- Fig. 58 China cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 59 India Key country dynamics
- Fig. 60 India cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 61 Australia Key country dynamics
- Fig. 62 Australia cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 63 South Korea Key country dynamics
- Fig. 64 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 65 Thailand Key country dynamics
- Fig. 66 Thailand cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 67 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 68 Brazil Key country dynamics
- Fig. 69 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 70 Argentina Key country dynamics
- Fig. 71 Argentina cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 72 Middle East and Africa cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 73 South Africa Key country dynamics
- Fig. 74 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 75 Saudi Arabia Key country dynamics
- Fig. 76 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 77 UAE Key country dynamics
- Fig. 78 UAE cell reprogramming market, 2018 - 2030 (USD Million)
- Fig. 79 Kuwait Key country dynamics
- Fig. 80 Kuwait cell reprogramming market, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.